2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Lopez-Pereira, P, Domínguez, SR, Martin-Moro, F, Caballero, AC, García, AL, Benito, BD, Sarto, MF, Vicente, FD, Marín, JL, Marino, SP, Jiménez-Ubieto, A, Cabirta, A, Gutiérrez, NC, Chulvi, MJL, Puyuelo, A, Prat, AM, Coello, AP, García-Lerma, E, Vilchez, SM. Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis. BONE MARROW TRANSPL -. 27 nov 2025. 1 nov 2025. . F.I.:5,200 [doi:10.1038/s41409-025-02772-2]
Spencer, A, Gavriatopoulou, M, Coriu, D, Lysen, A, Gutierrez, NC, Escalante, F, Fantl, DBE, Hajek, R, Seguro, F, Kaur, G, Bittencourt, R, Kinda, SB, Chu, MP, Safah, H, Martinez-Lopez, J, Crusoe, ED, De Farias, DLC, Offidani, M, Askari, E, Sevindik, ÖG, Maisnar, V, Teng, CL, Hughes, O, Taylor, R, Lehn, K, Feng, D, Thiebaut-Millot, R, Li, XT, Murray, L, Jung, PL, Rossi, EL, Kongpachith, S, Nichol, A, Ross, JA, Hader, C. Prospective real-world evaluation of t(11;14) prevalence and disease biology in multiple myeloma: MEDICI study analysis. BLOOD ADV 9 5814-5827. 25 nov 2025. 1 nov 2025. . F.I.:7,100 [doi:10.1182/bloodadvances.2025017214]

Lopez-Blanch, L, Rodríguez-Marin, C, Mantica, F, Iñiguez, LP, Permanyer, J, Kita, EM, Mackensen, T, Codina-Tobias, M, Romero-Ferrero, F, Fernandez-Albert, J, Cuadrado, M, Bustelo, XR, De Polavieja, G, Irimia, M. Phenotypic impact of individual conserved neuronal microexons and their master regulators in zebrafish. ELIFE 13 -. 18 nov 2025. . . F.I.:6,400 [doi:10.7554/eLife.104275; 10.7554/eLife.104275.3.sa1; 10.7554/eLife.104275.3.sa2; 10.7554/eLife.104275.3.sa3]

Cardona-Benavides, IJ, Cristobal-Vargas, S, De Ramón, C, Rojas, EA, Misiewicz-Krzeminska, I, Isidro, I, Pérez, JJ, Paiva, B, Puig, N, Alcoceba, M, Mateos, MV, Corchete, LA, Cuadrado, M, Gutiérrez, NC. Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation. MOL ONCOL 19 3175-3192. 1 nov 2025. 1 jul 2025. . F.I.:4,500 [doi:10.1002/1878-0261.70085]

Alejo, E, González-Calle, V, Blázquez, P, Puertas, B, Agulló, C, Rey-Búa, B, Gutiérrez, NC, Puig, N, Mateos, MV. Hypoalbuminemia: a new risk factor for progression in patients with monoclonal gammopathy of uncertain significance. BLOOD CANCER J 15 -. 24 oct 2025. . . F.I.:11,600 [doi:10.1038/s41408-025-01371-0]

Bolli, N, D'Agostino, M, Bagratuni, T, Boccadoro, M, Cavo, M, Driessen, C, Einsele, H, Engelhardt, M, Gay, F, Gutiérrez, NC, Hájek, R, Holien, T, Joao, C, Kaiser, M, Kortüm, KM, Leypoldt, L, Moreau, P, Musto, P, Ocio, EM, Raab, MS, Rasche, L, Schjesvold, F, Sevcikova, T, Terpos, E, Touzeau, C, Van de Donk, NWCJ, van Duin, M, Weisel, K, Zamagni, E, Cupedo, T, Sonneveld, P, Terragna, C. European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma. HEMASPHERE 9 -. 13 oct 2025. . . F.I.:14,600 [doi:10.1002/hem3.70216]

Lahuerta, JJ, San-Miguel, J, Jiménez-Ubieto, A, Alonso, R, Paiva, B, Puig, N, Cedena, MT, Gutierrez, NC, Calasanz, MJ, Guijarro, MF, Tamayo, RR, Rocafiguera, AO, Blanchard, MJ, Cruz, EC, Martínez-Martínez, R, Bargay, J, Balari, AS, de la Rubia, J, García, MTH, Cabañas, V, Montero, FC, Bernal, LP, Montes, YG, Martínez-Lopez, J, Rodriguez-Otero, P, Krisnik, I, Arguiñano, JM, García, MEG, Ocio, EM, de la Cruz, J, Mateos, MV, Rosiñol, L, Bladé, J, Spanish Myeloma Grp. High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial. BLOOD 146 1747-1758. 9 oct 2025. 1 oct 2025. . F.I.:23,100 [doi:10.1182/blood.2025028313]
Avet-Loiseau, H, Davies, FE, Samur, MK, Corre, J, D'Agostino, M, Kaiser, MF, Raab, MS, Weinhold, N, Gutierrez, NC, Paiva, B, Neri, P, Weisel, K, Maura, F, Walker, BA, Bustoros, M, Stewart, AK, Usmani, SZ, Hillengass, J, Chng, WJ, Keats, JJ, Martinez-Lopez, J, Sperling, AS, Touzeau, C, Zhan, FH, Raje, NS, Cavo, M, Bolli, N, Ghobrial, IM, Dhodapkar, MV, Jagannath, S, Spencer, A, Parekh, S, Bahlis, NJ, Lonial, S, Sonneveld, P, Bergsagel, L, Orlowski, RZ, Morgan, G, Mateos, MV, Rajkumar, SV, San Miguel, JF, Anderson, KC, Moreau, P, Kumar, S, Prosper, F, Munshi, NC. International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma. J CLIN ONCOL 43 2739-2751. 20 ago 2025. . . F.I.:41,900 [doi:10.1200/JCO-24-01893]
Kaiser, MF, Sonneveld, P, Cairns, DA, Raab, MS, Izquierdo, JSM, Zhang, R, Acosta, J, Larocca, A, Popat, R, Li, C, Baertsch, MA, Brown, SR, Palacios, JL, Gandhi, AK, Macé, S, Musto, P, Yong, K, Mai, EK, Dubin, F, Blade, J, Capra, A, Cook, G, Bertsch, U, Mateos, MV, Boccadoro, M, Jackson, GH, Gutiérrez, NC, Gay, F, Weinhold, N. Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma. J CLIN ONCOL 43 2679-2691. 20 ago 2025. . . F.I.:41,900 [doi:10.1200/JCO-24-01253]

Cristóbal-Vargas, S, Cuadrado, M, Gutiérrez, NC. MYC alterations in multiple myeloma: Genetic insights and prognostic impact. NEOPLASIA 66 -. 1 ago 2025. 1 may 2025. . F.I.:7,700 [doi:10.1016/j.neo.2025.101177]